LIFE: Analysis & Opinions

  1. Thermo Steps Up And Seals A Deal For Life Technologies

    April 19, 2013
    Speculation has been all over the place for an M&A with LifeTech, but the final announcement is consistent with my ...
  2. Life's Products Gain FDA Approval - Analyst Blog

    February 12, 2013
    Global biotechnology tools company - Life Technologies Corporation (LIFE) recently received 510(k) clearance from ...
  3. Genomic Beats Estimates - Analyst Blog

    February 08, 2013
    Genomic Health (GHDX) reported fourth-quarter 2012 net income of $2.0 million, down from $2.6 million in the ...
  4. LIFE Beats 4Q Rev, Misses EPS - Analyst Blog

    February 05, 2013
    Life Technologies Corporation (LIFE) reported earnings per share (EPS) of 63 cents in the fourth quarter of fiscal ...
  5. Life Technologies: Preview - Analyst Blog

    February 04, 2013
    Life Technologies (LIFE) is scheduled to report its fourth-quarter and fiscal 2012 results on Monday, Feb 4, 2013, ...
  6. Illumina Posts an Impressive 4Q - Analyst Blog

    January 29, 2013
    Illumina (ILMN) reported fourth quarter 2012 adjusted earnings per share ("EPS") of 42 cents, beating the Zacks ...
  7. Luminex Wins FDA Clearance - Analyst Blog

    January 16, 2013
    Luminex Corporation (LMNX) recently revealed that it won clearance from the FDA for its xTAG Gastrointestinal ...
  8. Illumina to Buy Verinata - Analyst Blog

    January 07, 2013
    In order to expand its footprint in the prenatal testing market, Illumina Inc. (ILMN), a major developer of life ...
  9. Has Roche Said "Nein" To Illumina's Asking Price Once More?

    January 07, 2013
    Roche may have walked away from Illumina for good.
  10. Healthcare Stocks, Including Thermo Fisher, Making Big ...

    December 21, 2012
    On a bad day for the market, the Nasdaq has slipped 2%, the S&P 500 is trading down 1.9% and the Dow is down 1.4%. ...
  11. Luminex Retained at Neutral - Analyst Blog

    December 18, 2012
    Luminex Corporation's (LMNX) third quarter 2012 adjusted earnings of $0.04 per share missed the Zacks Consensus ...
  12. Bio-Rad to Buy AbD Serotec - Analyst Blog

    December 17, 2012
    Bio-Rad Laboratories (BIO), a worldwide provider of life science research and clinical diagnostic products, recently ...
  13. Life Technologies Stays Neutral - Analyst Blog

    December 07, 2012
    We have reaffirmed our Neutral recommendation on Life Technologies (LIFE) with a target price of $52.00. The ...
  14. LIFE Beefs Up Diagnostic Portfolio - Analyst Blog

    November 26, 2012
    Recently, Life Technologies Corporation (LIFE) announced the launch of its Applied Biosystems QuantStudio Dx ...
  15. Agilent's Grim Guidance Obscures Long-Term Value

    November 20, 2012
    Agilent's guidance points to another tough year.
  16. Thermo Fisher Remains Neutral - Analyst Blog

    November 13, 2012
    We reiterate our Neutral recommendation on Thermo Fisher Scientific (TMO) with a target price of $55.00. Thermo ...
  17. Mixed 3Q for Genomic Health - Analyst Blog

    November 08, 2012
    Genomic Health (GHDX) reported third quarter 2012 net income of $3.7 million, up from $3.2 million in the year-ago ...
  18. Qiagen Misses on EPS, Revs Beat - Analyst Blog

    November 06, 2012
    Qiagen (QGEN) reported third quarter 2012 earnings per share (EPS) of 12 cents, compared to 15 cents in the year-ago ...
  19. Will It Be Even Harder For Life Tech To Muddle Through ...

    November 05, 2012
    Life Tech has the right technology, but 2013 could be a challenging year for the sector.
  20. Life Beats, FX Headwind Continues - Analyst Blog

    November 02, 2012
    Life Technologies Corporation (LIFE) reported earnings per share ("EPS") of 55 cents in the third quarter of fiscal ...
Marketplace
Trading Center